Novelty processing and memory impairment in Alzheimer's disease: A review.


Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
05 2019
Historique:
received: 10 09 2018
revised: 24 12 2018
accepted: 28 02 2019
pubmed: 10 3 2019
medline: 27 6 2019
entrez: 10 3 2019
Statut: ppublish

Résumé

The detection and processing of novelty plays a critical role in memory function. Despite this, relatively little is known about how novelty influences memory in Alzheimer's disease (AD). This review sought to address whether AD patients are still sensitive to novelty; whether novelty triggers memory processes as is observed in healthy subjects; and whether it is possible to promote novelty to enhance memory at the different stages of AD. The studies reviewed showed that novelty processing is mostly impaired in AD patients, whereas it can be preserved under some conditions in MCI, particularly when cognitive demands are otherwise low. We further identify outstanding questions that should be addressed in the near future in order to more robustly establish the fate of novelty processing and detection in the course of AD. Doing so would allow to improve current models of memory impairment in AD, leading to a more comprehensive view of the sources of memory decline and could lead to neuropsychological and/or pharmaceutical rehabilitation programs.

Identifiants

pubmed: 30851282
pii: S0149-7634(18)30680-8
doi: 10.1016/j.neubiorev.2019.02.021
pii:
doi:

Substances chimiques

Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-249

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Christine Bastin (C)

GIGA-CRC In vivo Imaging, Liège University, Allée du 6 Août, B30, 4000 Liège, Belgium. Electronic address: Christine.Bastin@uliege.be.

Emma Delhaye (E)

GIGA-CRC In vivo Imaging, Liège University, Allée du 6 Août, B30, 4000 Liège, Belgium. Electronic address: Emma.Delhaye@uliege.be.

Christopher Moulin (C)

Psychology and Neurocognition Laboratory, CNRS UMR 5105, Université Grenoble Alpes, Bâtiment Sciences de l'Homme et Mathématiques, 1251 avenue Centrale, Domaine Universitaire de St Martin d'Hères, 38040 Grenoble, France. Electronic address: chris.moulin@mac.com.

Emmanuel J Barbeau (EJ)

Centre de recherche Cerveau et Cognition, UPS-CNRS UMR 5549, CHU Purpan, Pavillon Baudot, 31059 Toulouse cedex 9, France. Electronic address: Emmanuel.BARBEAU@cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH